SERPINA1 and hepatocellular carcinoma: Other studies on the development of HCC have shown that it leads to changes in hemochromatosis, α1‐antitrypsin deficiency (SERPINA1), glycogen storage disease (G6PC, SLC37A4), tyrosinemia (FAH), porphyria (HMBS, UROD), and Wilson disease (ATP7B).